Amylin Pharmaceuticals Inc
AMLN · Chemicals & Drugs · NASDAQ · in our data January 17, 1992 to August 8, 2012 (20.6 years)
The first trading day in our data for Amylin Pharmaceuticals Inc is January 17, 1992 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on October 5, 2007, the market valued it at $6.8 billion. It left the market when it was bought or merged, last trading at $30.98, -39.8% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 1992. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2012: Chemicals & Drugs
- Human Genome Sciences Inc peaked at $11.1 billion
- Pharmasset Inc peaked at $10.4 billion
- Gen-probe Inc peaked at $4.2 billion
- Solutia Inc peaked at $3.5 billion
- Medicis Pharmaceut CP peaked at $2.7 billion
- Par Pharmaceutcl Hldgs -redh peaked at $2.5 billion
